Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 100 results.
User Information
Export Records
  1. 1.   A Molecular Networking Strategy: High-Throughput Screening and Chemical Analysis of Brazilian Cerrado Plant Extracts against Cancer Cells
  2. Cortelo, Patricia C.; Demarque, Daniel P.; Dusi, Renata G.; Albernaz, Lorena C.; Braz-Filho, Raimundo; Goncharova, Ekaterina I.; Bokesch, Heidi R.; Gustafson, Kirk R.; Beutler, John A.; Espindola, Laila S.
  3. Cells. 2021, Mar; 10(3):
  1. 2.   Molecular Genomic Features Associated with in Vitro Response of the NCI-60 Cancer Cell Line Panel to Natural Products
  2. Krushkal, Julia; Negi, Simarjeet; Yee, Laura M; Evans,Jason; Grkovic,Tanja; Palmisano, Alida; Fang, Jianwen; Sankaran, Hari; McShane, Lisa M; Zhao, Yingdong; O'Keefe,Barry
  3. Molecular oncology. 2020, NOV 24;
  1. 3.   Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma
  2. Shankavaram, U. T.; Bredel, M.; Burgan, W. E.; Carter, D.; Tofilon, P.; Camphausen, K.
  3. Journal of Cellular and Molecular Medicine. 2012, Mar; 16(3): 545-554.
  1. 4.   Synthesis and Anticancer Activity of 13-Membered Cyclic Enediynes
  2. Sharma, M.; Joshi, M. C.; Kumar, V.; Malhotra, S. V.; Rawat, D. S.
  3. Archiv Der Pharmazie. 2011, Sep; 344(9): 564-571.
  1. 5.   Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1
  2. Borges, A. R.; Wieczorek, L.; Johnson, B.; Benesi, A. J.; Brown, B. K.; Kensinger, R. D.; Krebs, F. C.; Wigdahl, B.; Blumenthal, R.; Puri, A.; McCutchan, F. E.; Birx, D. L.; Polonis, V. R.; Schengrund, C. L.
  3. Virology. 2010, Dec; 408(1): 80-88.
  1. 6.   MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
  2. Salcedo, R.; Worschech, A.; Cardone, M.; Jones, Y.; Gyulai, Z.; Dai, R. M.; Wang, E. N.; Ma, W.; Haines, D.; O'HUigin, C.; Marincola, F. M.; Trinchieri, G.
  3. Journal of Experimental Medicine. 2010, Aug 2; 207(8): 1625-1636.
  1. 7.   mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities
  2. Liu, H. F.; D'Andrade, P.; Fulmer-Smentek, S.; Lorenzi, P.; Kohn, K. W.; Weinstein, J. N.; Pommier, Y.; Reinhold, W. C.
  3. Molecular Cancer Therapeutics. 2010, May; 9(5): 1080-1091.
  1. 8.   Exon Array Analyses across the NCI-60 Reveal Potential Regulation of TOP1 by Transcription Pausing at Guanosine Quartets in the First Intron
  2. Reinhold, W. C.; Mergny, J. L.; Liu, H. F.; Ryan, M.; Pfister, T. D.; Kinders, R.; Parchment, R.; Doroshow, J.; Weinstein, J. N.; Pommier, Y.
  3. Cancer Research. 2010, Mar; 70(6): 2191-2203.
  1. 9.   In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase
  2. Chung, E. J.; Brown, A. P.; Asano, H.; Mandler, M.; Burgan, W. E.; Carter, D.; Camphausen, K.; Citrin, D.
  3. Clinical Cancer Research. 2009 15(9): 3050-3057.
  1. 10.   Experimental validation for quantitative protein network models
  2. Nishizuka, S.; Spurrier, B.
  3. Current Opinion in Biotechnology. 2008 19(1): 41-49.
  1. 11.   Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors
  2. Khan, T.; Stauffer, J. K.; Williams, R.; Hixon, J. A.; Salcedo, R.; Lincoln, E.; Back, T. C.; Powell, D.; Lockett, S.; Arnold, A. C.; Sayers, T. J.; Wigginton, J. M.
  3. Journal of Immunology. 2006, MAY 15; 176(10): 6302-6312.
  1. 12.   Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion
  2. Rawat, S. S.; Viard, M.; Gallo, S. A.; Blumenthal, R.; Puri, A.
  3. Glycoconjugate Journal. 2006, MAY; 23(3-4): 189-197.
  1. 13.   AbMiner: A bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies
  2. Major, S. M.; Nishizuka, S.; Morita, D.; Rowl, R.; Sunshine, M.; Shankavaram, U.; Washburn, F.; Asin, D.; Kouros-Mehr, H.; Kane, D.; Weinstein, J. N.
  3. Bmc Bioinformatics. 2006, Apr; 7
  1. 14.   Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: Functional similarity to the human disease and identification of prospective tumoral markers and targets
  2. Urzua, U.; Roby, K. F.; Gangi, L. M.; Cherry, J. M.; Powell, J. I.; Munroe, D. J.
  3. Journal of Cellular Physiology. 2006, MAR; 206(3): 594-602.
  1. 15.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 16.   CB694, a novel antimitotic with antitumor activities
  2. Weiderhold, K. N.; Randall-Hiubek, D. A.; Polin, L. A.; Hamel, E.; Mooberry, S. L
  3. International Journal of Cancer. 2006, FEB 15; 118(4): 1032-1040.
  1. 17.   Role of GADD34 in modulation of cisplatin cytotoxicity
  2. Fishel, M. L.; Rabik, C. A.; Bleibel, W. K.; Li, X. M.; Moschel, R. C.; Dolan, M. E.
  3. Biochemical Pharmacology. 2006, JAN 12; 71(3): 239-247.
  1. 18.   Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
  2. Sayers, T. J.; Murphy, W. J.
  3. Cancer Immunology Immunotherapy. 2006, JAN; 55(1): 76-84.
  1. 19.   Spreading of methylation within RUNX3 CpG island in gastric cancer
  2. Homma, N.; Tamura, G.; Honda, T.; Matsumoto, Y.; Nishizuka, S.; Kawata, S.; Motoyama, T.
  3. Cancer Science. 2006, JAN; 97(1): 51-56.
  1. 20.   Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells
  2. Du, Y.; Jenkins, N. A.; Copeland, N. G.
  3. Blood. 2005, DEC 1; 106(12): 3932-3939.
  1. 21.   Truncation, deamidation, and oxidation of histone H2B in cells cultured with nickel(II)
  2. Karaczyn, A. A.; Golebiowski, F.; Kasprzak, K. S.
  3. Chemical Research in Toxicology. 2005, DEC; 18(12): 1934-1942.
  1. 22.   The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
  2. Nagl, N. G.; Patsialou, A.; Haines, D. S.; Dallas, P. B.; Beck, G. R.; Moran, E.
  3. Cancer Research. 2005, OCT 15; 65(20): 9236-9244.
  1. 23.   Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells
  2. Wallqvist, A.; Huang, R.; Covell, D. G.; Roschke, A. V.; Gelhaus, K. S.; Kirsch, I. R.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1559-1568.
  1. 24.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 25.   Heparan sulfate Proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4(+) T cells
  2. Jones, K. S.; Petrow-Sadowski, C.; Bertolette, D. C.; Huang, Y.; Ruscetti, F. W.
  3. Journal of Virology. 2005, OCT; 79(20): 12692-12702.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel